Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses

Elife. 2018 Jun 19:7:e34273. doi: 10.7554/eLife.34273.

Abstract

Type I interferon (IFN-I) responses are critical for the control of RNA virus infections, however, many viruses, including Dengue (DENV) and Chikungunya (CHIKV) virus, do not directly activate plasmacytoid dendritic cells (pDCs), robust IFN-I producing cells. Herein, we demonstrated that DENV and CHIKV infected cells are sensed by pDCs, indirectly, resulting in selective IRF7 activation and IFN-I production, in the absence of other inflammatory cytokine responses. To elucidate pDC immunomodulatory functions, we developed a mouse model in which IRF7 signaling is restricted to pDC. Despite undetectable levels of IFN-I protein, pDC-restricted IRF7 signaling controlled both viruses and was sufficient to protect mice from lethal CHIKV infection. Early pDC IRF7-signaling resulted in amplification of downstream antiviral responses, including an accelerated natural killer (NK) cell-mediated type II IFN response. These studies revealed the dominant, yet indirect role of pDC IRF7-signaling in directing both type I and II IFN responses during arbovirus infections.

Keywords: dendritic cells; human; immunology; inflammation; interferons; mouse; virology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chikungunya Fever / genetics
  • Chikungunya Fever / immunology*
  • Chikungunya Fever / mortality
  • Chikungunya Fever / pathology
  • Chikungunya virus / growth & development
  • Chikungunya virus / immunology
  • Chikungunya virus / pathogenicity
  • Dendritic Cells / immunology
  • Dendritic Cells / virology
  • Dengue / genetics
  • Dengue / immunology*
  • Dengue / mortality
  • Dengue / pathology
  • Dengue Virus / growth & development
  • Dengue Virus / immunology
  • Dengue Virus / pathogenicity
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation
  • Host-Pathogen Interactions / immunology*
  • Humans
  • Interferon Regulatory Factor-3 / deficiency
  • Interferon Regulatory Factor-3 / genetics
  • Interferon Regulatory Factor-3 / immunology*
  • Interferon Regulatory Factor-7 / deficiency
  • Interferon Regulatory Factor-7 / genetics
  • Interferon Regulatory Factor-7 / immunology*
  • Interferon Type I / genetics
  • Interferon Type I / immunology*
  • Interferon-gamma / genetics
  • Interferon-gamma / immunology
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / virology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • RNA, Viral / antagonists & inhibitors
  • RNA, Viral / genetics
  • RNA, Viral / immunology
  • Signal Transduction
  • Spleen / immunology
  • Spleen / virology
  • Survival Analysis

Substances

  • Interferon Regulatory Factor-3
  • Interferon Regulatory Factor-7
  • Interferon Type I
  • Irf3 protein, mouse
  • Irf7 protein, mouse
  • RNA, Viral
  • Interferon-gamma

Grants and funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.